Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term 'Hepatoprotective' describes a pharmacological property or therapeutic effect rather than a specific molecular target like a receptor or enzyme. It refers to the ability of a substance to prevent damage to the liver (hepatocytes) caused by toxins, oxidative stress, or inflammatory processes. Hepatoprotective agents are often used in the management of liver disorders such as drug-induced liver injury, chronic hepatitis, and cirrhosis. These substances typically exert their effects by enhancing the liver's natural antioxidant defenses, stabilizing cellular membranes, or promoting the regeneration of liver tissue. Because 'Hepatoprotective' is a functional descriptor of a drug's action and not a distinct biological molecule, it is considered an incorrect entry for a specific therapeutic target database.
Hepatoprotective agents work through various mechanisms including scavenging free radicals, inhibiting the activity of cytochrome P450 enzymes involved in toxin activation, stabilizing hepatocyte membranes to prevent toxin entry, and promoting the synthesis of ribosomal RNA to facilitate liver regeneration.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatoprotective.